VI
ICPT

Versor Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Versor Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-378,480
Closed -$7.02M – 904
2023
Q3 		$7.02M Buy
+378,480
New +$4.28M 1.42% 5

Versor Investments's ICPT Position: Q4 2023 in Review

Versor Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 378,480 shares — an estimated $7.02M sold.

Versor Investments first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $7.02M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Versor Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Versor Investments sold 378,480 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $7.02M.
  • Versor Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Versor Investments's Intercept Pharmaceuticals, Inc. position peaked at $7.02M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Versor Investments's 13F filing for Q4 2023, filed 7 Feb 2024.